2024 Alzheimer’s disease facts and figures. Alzheimers Dement. 2024;20(5):3708–3821. https://doi.org/10.1002/alz.13809

Kunkle BW, Vardarajan BN, Naj AC, Whitehead PL, Rolati S, Slifer S, et al. Early-Onset Alzheimer Disease and Candidate Risk Genes Involved in Endolysosomal Transport. Jama Neurol. 2017;74(9):1113–22. https://doi.org/10.1001/jamaneurol.2017.1518.

Article  PubMed  PubMed Central  Google Scholar 

Griffin P, Apostolova L, Dickerson BC, Rabinovici G, Salloway S, Brandt K, et al. Developments in understanding early onset Alzheimer’s disease. Alzheimers Dement. 2023;19(Suppl 9):S126–31. https://doi.org/10.1002/alz.13353.

Article  PubMed  PubMed Central  Google Scholar 

Camus V, Payoux P, Barre L, Desgranges B, Voisin T, Tauber C, et al. Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment. Eur J Nucl Med Mol Imaging. 2012;39(4):621–31. https://doi.org/10.1007/s00259-011-2021-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pemberton HG, Collij LE, Heeman F, Bollack A, Shekari M, Salvado G, et al. Quantification of amyloid PET for future clinical use: a state-of-the-art review. Eur J Nucl Med Mol Imaging. 2022;49(10):3508–28. https://doi.org/10.1007/s00259-022-05784-y.

Article  PubMed  PubMed Central  Google Scholar 

Tsai RM, Bejanin A, Lesman-Segev O, Lajoie R, Visani A, Bourakova V, et al. (18)F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Alzheimers Res Ther. 2019;11(1):13. https://doi.org/10.1186/s13195-019-0470-7.

Article  PubMed  PubMed Central  Google Scholar 

Gatchel JR, Rabin JS, Buckley RF, Locascio JJ, Quiroz YT, Yang HS, et al. Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults. Jama Netw Open. 2019;2(8):e198964. https://doi.org/10.1001/jamanetworkopen.2019.8964.

Article  PubMed  PubMed Central  Google Scholar 

Nitchingham A, Pereira JV, Wegner EA, Oxenham V, Close J, Caplan GA. Regional cerebral hypometabolism on 18F-FDG PET/CT scan in delirium is independent of acute illness and dementia. Alzheimers Dement. 2023;19(1):97–106. https://doi.org/10.1002/alz.12604.

Article  PubMed  Google Scholar 

Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA. 2015;313(19):1924–38. https://doi.org/10.1001/jama.2015.4668.

Article  PubMed  PubMed Central  Google Scholar 

Mastenbroek SE, Sala A, Vallez GD, Shekari M, Salvado G, Lorenzini L, et al. Continuous beta-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity. Neurology. 2024;103(1):e209419. https://doi.org/10.1212/WNL.0000000000209419.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haque R, Watson CM, Liu J, Carter EK, Duong DM, Lah JJ, et al. A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer’s disease. Sci Transl Med. 2023;15(712):eadg4122. https://doi.org/10.1126/scitranslmed.adg4122.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes AI, et al. Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial. Jama Neurol. 2023;80(6):548–57. https://doi.org/10.1001/jamaneurol.2023.0997.

Article  PubMed  PubMed Central  Google Scholar 

Wang W, Huang J, Qian S, Zheng Y, Yu X, Jiang T, et al. Amyloid-beta but not tau accumulation is strongly associated with longitudinal cognitive decline. Cns Neurosci Ther. 2024;30(7):e14860. https://doi.org/10.1111/cns.14860.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schindler SE, Galasko D, Pereira AC, Rabinovici GD, Salloway S, Suarez-Calvet M, et al. Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer’s Disease. Nat Rev Neurol. 2024;20(7):426–39. https://doi.org/10.1038/s41582-024-00977-5.

Article  CAS  PubMed  Google Scholar 

Saha P, Sen N, Tauopathy. A common mechanism for neurodegeneration and brain aging. Mech Ageing Dev. 2019;178:72–9. https://doi.org/10.1016/j.mad.2019.01.007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lv X, Cheng Z, Wang Q, Gao F, Dai L, Du C, et al. High burdens of phosphorylated tau protein and distinct precuneus atrophy in sporadic early-onset Alzheimer’s disease. Sci Bull (Beijing). 2023;68(22):2817–26. https://doi.org/10.1016/j.scib.2023.10.019.

Article  CAS  PubMed  Google Scholar 

Cho H, Mundada NS, Apostolova LG, Carrillo MC, Shankar R, Amuiri AN, et al. Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS). Alzheimers Dement. 2023;19(Suppl 9):S98–114. https://doi.org/10.1002/alz.13453.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hammers DB, Eloyan A, Taurone A, Thangarajah M, Gao S, Beckett L, et al. Longitudinal cognitive performance of participants with sporadic early onset Alzheimer’s disease from LEADS. Alzheimers Dement. 2025;21(2):e14439. https://doi.org/10.1002/alz.14439.

Article  PubMed  Google Scholar 

Visser D, Verfaillie S, Wolters EE, Coomans EM, Timmers T, Tuncel H, et al. Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2022;49(6):1951–63. https://doi.org/10.1007/s00259-021-05669-6.

Article  PubMed  PubMed Central  Google Scholar 

Katsumi Y, Touroutoglou A, Brickhouse M, Eloyan A, Eckbo R, Zaitsev A, et al. Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer’s disease: A head-to-head comparison of the LEADS and ADNI cohorts. Alzheimers Dement. 2025;21(2):e14489. https://doi.org/10.1002/alz.14489.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vanhoutte M, Semah F, Lopes R, Jaillard A, Petyt G, Aziz AL, et al. Using EQ.PET to reduce reconstruction-dependent variations in [(18)F]FDG-PET brain imaging. Phys Med Biol. 2019;64(17):175002. https://doi.org/10.1088/1361-6560/ab35b4.

Article  CAS  PubMed  Google Scholar 

Nemes S, Logan PE, Manchella MK, Mundada NS, La Joie R, Polsinelli AJ, et al. Sex and APOE epsilon4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer’s disease. Alzheimers Dement. 2023;19(Suppl 9):S49–63. https://doi.org/10.1002/alz.13403.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C. Early-Onset Alzheimer’s Disease: What Is Missing in Research? Curr Neurol Neurosci Rep. 2021;21(2):4. https://doi.org/10.1007/s11910-020-01090-y.

Article  PubMed  PubMed Central  Google Scholar 

Kang JM, Shin JH, Kim WR, Seo S, Seo H, Lee SY, et al. Effects of the APOEvarepsilon4 Allele on the Relationship Between Tau and Amyloid-beta in Early- and Late-Onset Alzheimer’s Disease. J Alzheimers Dis. 2023;94(3):1233–46. https://doi.org/10.3233/JAD-230339.

Article  CAS  PubMed  Google Scholar 

Sirkis DW, Bonham LW, Johnson TP, La Joie R, Yokoyama JS. Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease. Mol Psychiatry. 2022;27(6):2674–88. https://doi.org/10.1038/s41380-022-01531-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cho H, Seo SW, Kim JH, Suh MK, Lee JH, Choe YS, et al. Amyloid deposition in early onset versus late onset Alzheimer’s disease. J Alzheimers Dis. 2013;35(4):813–21. https://doi.org/10.3233/JAD-121927.

Article  CAS  PubMed  Google Scholar 

Chang Y, Liu J, Xu X, Sun S, Zhang J, Zhang X, et al. Subcortical tau deposition and plasma glial fibrillary acidic protein as predictors of cognitive decline in mild cognitive impairment and Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2025;52(4):1496–509. https://doi.org/10.1007/s00259-024-07016-x.

Article